Treatment options for acute myeloid leukemia (AML) in seniors have remained stagnant for 40 years. We are participating in Beat AML, a research study focused on swift phenotyping and tailored therapies, with the ultimate goal of improving outcomes in this disease that otherwise becomes increasingly difficult to treat as patients age.
Breast cancer clinical trials are not experiments. Rather, they are options for women with breast cancer to receive the gold standard of cancer care paired with advanced therapies that can greatly improve their outcomes.
Should women stop using hormonal birth control because of a slightly increased risk of breast cancer? Dr. Bruce Carr says no. Discover how to weigh the risks and benefits of these contraceptives and others.
Kidney cancer patients may see long-lasting tumor shrinkage with immunotherapy, which uses the immune system as a weapon to fight cancer. Learn more.
Kidney cancer often doesn’t respond well to conventional radiation therapies, but a certain type of high-dose radiation therapy is proving effective.
As of Sept. 1, 2017, all Texas health insurance plans must cover 3-D mammograms for women 35+. What this means for women’s health.
Large kidney tumors or those starting to spread can put patients’ lives at risk. Learn about robotic surgery for kidney cancer and when we recommend it.
Learn how a breakthrough treatment trains children’s immune systems to fight back against leukemia.
Diagnosed at age 3 with a rare genetic disorder, Ryan Dant was not expected to live beyond age 10. But thanks to his parents who never lost hope and a clinical trial at UT Southwestern, the now 29-year-old recently finished college and is looking forward to life’s next chapter. “It’s an incredible story,” says UTSW’s Elizabeth Maher, M.D., Ph.D., one of the specialists on his team.
Not every kidney tumor needs treatment right away, if at all. Learn about active monitoring of early-stage kidney cancer and when we recommend it.